Author: Caspian Hartwell

Hatch-Waxman Act: How It Created the Modern Generic Drug Market in the U.S. +
7 Mar

Hatch-Waxman Act: How It Created the Modern Generic Drug Market in the U.S.

The Hatch-Waxman Act of 1984 created the modern U.S. generic drug market by balancing patent protections for innovators with faster approval for generics. It now governs 90% of prescriptions and saves $313 billion annually.

Polypharmacy in Elderly Patients: How to Manage Multiple Medications Safely +
6 Mar

Polypharmacy in Elderly Patients: How to Manage Multiple Medications Safely

Polypharmacy in elderly patients - taking five or more medications - increases risks of falls, confusion, and hospitalization. Learn how deprescribing, medication reviews, and teamwork between doctors and pharmacists can improve safety and quality of life for seniors.

G6PD Deficiency and Medications: How to Prevent Hemolysis +
3 Mar

G6PD Deficiency and Medications: How to Prevent Hemolysis

G6PD deficiency can cause life-threatening hemolysis when exposed to certain medications. Learn which drugs to avoid, safe alternatives, and how testing prevents emergencies. Over 400 million people worldwide are affected - prevention saves lives.

The 80-125% Rule: Understanding Bioequivalence Confidence Intervals for Generic Drugs +
27 Feb

The 80-125% Rule: Understanding Bioequivalence Confidence Intervals for Generic Drugs

The 80-125% rule ensures generic drugs are absorbed the same way as brand-name versions. It's not about drug content-it's about how your body processes it. Here's how it works, why it matters, and what it really means for patients.

Prior Authorization for NTI Drugs: When Insurers Require Brand-Name Medications +
24 Feb

Prior Authorization for NTI Drugs: When Insurers Require Brand-Name Medications

NTI drugs like levothyroxine and phenytoin require brand-name consistency for patient safety-but many insurers still force prior authorization for generics. Learn why this practice is dangerous, how state laws are changing, and what patients can do to protect their treatment.

How to Build Patient Confidence in Generic Medications: Proven Strategies Based on Research +
20 Feb

How to Build Patient Confidence in Generic Medications: Proven Strategies Based on Research

Generic medications save billions but face patient skepticism. Research shows clear, honest communication from doctors and pharmacists is the most effective way to build trust and improve adherence.

Boxed Warning Changes: Tracking FDA Label Updates Over Time +
17 Feb

Boxed Warning Changes: Tracking FDA Label Updates Over Time

Boxed warnings are the FDA's strongest safety alerts for prescription drugs. Tracking their changes over time is critical for safe prescribing. Learn how the SrLC database works, why updates lag, and how clinicians can stay informed.

Pediatric Safety: What Parents and Providers Need to Know About Generic Drugs for Children +
14 Feb

Pediatric Safety: What Parents and Providers Need to Know About Generic Drugs for Children

Generic drugs for children aren't always safe. Differences in inactive ingredients, dosing, and children's unique physiology can lead to serious harm. Learn what parents and providers need to know to protect kids.

How to Prepare for Pediatric Procedures with Pre-Op Medications +
10 Feb

How to Prepare for Pediatric Procedures with Pre-Op Medications

Learn how to safely prepare your child for surgery with proper pre-op medications, fasting rules, and anxiety management. Follow evidence-based guidelines to reduce risks and improve outcomes.

Acetaminophen Safety: How to Avoid Overdose and Stay Safe +
7 Feb

Acetaminophen Safety: How to Avoid Overdose and Stay Safe

Acetaminophen is safe when used correctly, but accidental overdose is the leading cause of acute liver failure in the U.S. Learn how to avoid hidden doses, recognize warning signs, and act fast if you've taken too much.